2010-023946-58: Immunogenicity and safety of an adjuvant hepatitis B vaccine (fendrix) compared to Engerix in non-responding HIV-infected patients |
|
|
| Ongoing | 2 | 100 | Europe | Fendrix, Fendrix | ErasmusMC | We want to study the efficacy of Fendrix, a new adjuvant hepatitis B vaccin, in HIV infected patients, who failed to respond on intial standard and subsequent booster Hepatitis b vaccinations. We want to compare the efficacy of Fendrix to the efficacy of a double dose of the standard hepatitis b vaccinations, Engerix | | | | |
NCT04398706: Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants |
|
|
| Completed | 2 | 853 | Canada, US, RoW | Pneumococcal Conjugate Vaccine formulation 1, SP0202-IIb, Pneumococcal Conjugate Vaccine formulation 2, SP0202-VI, Pneumococcal Conjugate Vaccine formulation 3, SP0202-VII, Varicella Virus Vaccine Live, Varicella vaccine, VARIVAX®, Measles, Mumps, and Rubella Virus Vaccine Live, MMR vaccine, M-M-R ®II, Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Prevnar 13®, Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate), DTaP-IPV// Hib vaccine, Pentacel®, Rotavirus Vaccine, Live, Oral, Pentavalent, Rotavirus vaccine, RotaTeq, Hepatitis B Vaccine* [Recombinant] *as applicable, Hepatitis B vaccine, ENGERIX-B® | Sanofi Pasteur, a Sanofi Company | Pneumococcal Immunisation, Diphtheria Immunisation, Tetanus Immunisation, Pertussis Immunisation, Hepatitis B Immunisation, Haemophilus Influenzae Type b Immunisation, Polio Immunisation, Measles Immunisation, Rubella Immunisation, Varicella Immunisation, Mumps Immunisation | 08/23 | 08/23 | | |
2021-005629-25: A study on the safety and immune response of AS37 together with Hepatitis B antigen in adults aged 18-45 years |
|
|
| Not yet recruiting | 1/2 | 150 | Europe | GSKVx000000030242, GSKVx000000030083, GSKVx000000030451, Powder and suspension for suspension for injection, Suspension for injection, Emulsion for emulsion for injection, Fendrix, Engerix-B Erwachsene | GlaxoSmithKline Biologicals SA, GlaxoSmithKline Biologicals, GlaxoSmithKline Biologicals SA | Healthy volunteers (Hepatitis B Virus infection), Hepatitis B virus (HBV) infection, especially chronic infection, is a significant worldwide medical problem that affects the liver, Diseases [C] - Virus Diseases [C02] | | | | |
NCT03910972: Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults |
|
|
| Active, not recruiting | 1/2 | 290 | RoW | Sm-TSP-2/Alhydrogel® vaccine, Sm-TSP-2/Alhydrogel® vaccine plus AP 10-701, ENGERIX-B Hepatitis B Vaccine | Baylor College of Medicine, George Washington University, Makerere University Walter Reed Project | Schistosomiasis, Schistosoma Mansoni | 09/24 | 09/24 | | |
HBV003, NCT03038802: A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection |
|
|
| Not yet recruiting | 1/2 | 40 | RoW | Therapeutic hepatitis B vaccine, Hepadvax(TM), Commercial Hepatitis B vaccine, Engerix B | Vaxine Pty Ltd, Australian Respiratory and Sleep Medicine Institute | Chronic Hepatitis b | 12/25 | 12/26 | | |
